← Every applicant
Rhodes Pharms FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| MARAVIROCNew drugNov 4, 2025TABLET, ORAL |
| VARENICLINE TARTRATENew drugMay 21, 2025TABLET, ORAL |
| SCOPOLAMINENew drugMay 6, 2024SYSTEM, TRANSDERMAL |
| LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023CAPSULE, ORAL |
| THEOPHYLLINENew drugMay 11, 2023TABLET, EXTENDED RELEASE, ORAL |
| METHYLPHENIDATE HYDROCHLORIDENew drugMay 31, 2022TABLET, EXTENDED RELEASE, ORAL |
| AMPHETAMINE SULFATENew drugSep 7, 2021TABLET, ORAL |
| DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugJan 13, 2021TABLET, ORAL |